Skip to content
Recall Observatory FDA recall evidence

Drug product

DOXOrubicin Hydrochloride Liposome Injection, 20 mg/10 ml (2 mg/mL), 10 mL Single Use Vial, Distributed by: Sun Pharmaceutical Industries , Inc. Cranbury, NJ 08512. Manufactured by: Sun Pharmaceutical Ind. Ltd. Halol-Baroda Highway. Halol-389 350, Gujarat, India. NDC 47335-049-40

D-0229-2018

January 16, 2018

Class II

Product summary

Firm
Sun Pharmaceutical Industries, Inc.
Event
Event 78947
Status
Terminated
Classification
Class II
Quantity
393 vials
Official record key
drug-enforcement:D-0229-2018

Official wording

Reason: Lack Of Assurance Of Sterility

Code information: Lot # JKS0403A Exp 02/2019

Distribution pattern: Product was distributed nationwide in the USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack Of Assurance Of Sterility